Categories: Entertainment

BAR LEONE IS CROWNED THE BEST BAR IN ASIA AT ASIA’S 50 BEST BARS FOR THE SECOND CONSECUTIVE YEAR

  • Bar Leone ranks No.1 and is named The Best Bar in Asia, sponsored by Perrier
  • The list features 20 new entries and establishments spanning 20 Asian destinations
  • Bangkok has seven bars on the list, as Bar Us ranks No.4 and is named The Best Bar in Thailand, sponsored by Amaro Lucano
  • Bangkok’s Vesper (No.29) wins the Rémy Martin Legend of the List Award
  • Sora (No.65) in Phnom Penh takes home the Ketel One Sustainable Bar Award 
  • Modernhaus (No.12) in Jakarta has been named the Three Cents Best New Opening Award recipient
  • Dry Wave Cocktail Studio (No.5) from Bangkok wins Disaronno Highest New Entry Award
  • Industry stalwart Jay Khan of Hong Kong and Shanghai’s Coa (No.17 and No.85, respectively) is crowned Roku Industry Icon
  • Alice in Seoul is named Nikka Highest Climber after rising 33 places in the rankings to No.13
  • Workshop14 (No.83) from Hanoi receives the Campari One To Watch Award 
  • Backdoor Bodega (No.64), Penang is the recipient of the Siete Misterios Best Cocktail Menu Award
  • Bangkok’s Messenger Service (No.90) takes home the Best Bar Design Award

For the full 1-50 list, please view here.

- Advertisement -

MACAU, July 15, 2025 /PRNewswire/ — Bar Leone in Hong Kong has clinched the coveted title of The Best Bar in Asia and The Best Bar in Hong Kong, sponsored by Perrier, for the second consecutive year, at the live awards ceremony for Asia’s 50 Best Bars 2025 in Macau.

- Advertisement -

Bar Leone made 50 Best history in 2024 by being the first-ever establishment to debut on the list at No.1 and as The Best Bar in Asia. Owned by Lorenzo Antinori, the menu features a carefully curated selection of classic cocktails, all while staying true to its identity as a neighbourhood bar.

- Advertisement -

At No.2 is Zest in Seoul, clinching the title of The Best Bar in Korea, sponsored by Tia Maria, while at No.3, Jigger & Pony is The Best Bar in Singapore, sponsored by Torres Brandy.

- Advertisement -

Emma Sleight, Head of Content for Asia’s 50 Best Bars, says: “We’re thrilled to gather in Macau with Asia’s vibrant and passionate drinks community. With 20 new entries, the most in recent years, this list is a testament to the boundary-pushing creativity of the region. Congratulations to Bar Leone for the incredible feat of retaining the No.1 spot.”

- Advertisement -

Media centre:
https://mediacentre.theworlds50best.com

- Advertisement -

Photo – https://mma.prnewswire.com/media/2731690/50_Best_Bar_Leone.jpg
PDF – https://mma.prnewswire.com/media/2728668/50_Best.pdf
Logo – https://mma.prnewswire.com/media/2718834/5387615/50_Best_Bars_2025_Logo.jpg

- Advertisement -

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/bar-leone-is-crowned-the-best-bar-in-asia-at-asias-50-best-bars-for-the-second-consecutive-year-302505712.html

- Advertisement -
PRNW Agency

Recent Posts

Ocular Therapeutix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

February 06, 2026 16:01 ET  | Source: Ocular Therapeutix, Inc. BEDFORD, Mass., Feb. 06, 2026…

10 hours ago

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

February 06, 2026 16:01 ET  | Source: NewAmsterdam Pharma N.V. NAARDEN, The Netherlands and MIAMI,…

10 hours ago

Novartis breaks ground on new global Biomedical Research center in San Diego to accelerate drug discovery

New facility will enable end‑to‑end discovery across key disease areas and technology platforms, joining existing…

10 hours ago

The Ministry of Finance and the International Monetary Fund to launch tomorrow the second edition of the AlUla Conference for Emerging Market Economies

AlUla, Saudi Arabia, Feb. 7, 2026 /PRNewswire/ -- The second edition of the AlUla Conference…

10 hours ago

Roches fenebrutinib is the first investigational medicine in over a decade that reduces disability progression in primary progressive multiple sclerosis (PPMS)

Late-breaking Phase III FENtrepid results presented at ACTRIMS show investigational fenebrutinib met its primary endpoint…

10 hours ago

Lexicon Announces Closing of Approximately $94.6 Million Public Offering and Concurrent Private Placement

February 06, 2026 17:17 ET  | Source: Lexicon Pharmaceuticals, Inc. THE WOODLANDS, Texas, Feb. 06,…

10 hours ago